CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) reported Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities of $0 for the 12-month period ending 2024-12-28, per its 10-K filed 2025-02-19.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities · last filed 2025-02-19
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2018-09-29 was $300.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2018-06-30 was $1.20M.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for the quarter ending 2014-03-29 was $24.00K.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2024 was $0.00.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2022 was $10.51M, a 462.25% increase from fiscal 2021.
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. unrecognized tax benefits, decrease resulting from settlements with taxing authorities for fiscal 2021 was $1.87M, a 68.08% decline from fiscal 2020.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 3 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 6 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities 12 month as first filed |
|---|---|---|---|---|
| 2024-12-28 | $0.00 10-K · filed 2025-02-19 | |||
| 2023-12-30 | $0.00 10-K · filed 2025-02-19 | |||
| 2022-12-31 | $10.51M 10-K · filed 2025-02-19 | |||
| 2021-12-25 | $1.87M 10-K · filed 2024-02-14 | |||
| 2020-12-26 | $5.86M 10-K · filed 2023-02-22 | |||
| 2019-12-28 | $274.00K 10-K · filed 2022-02-16 | |||
| 2018-12-29 | $3.38M 10-K · filed 2021-02-17 | |||
| 2018-09-29 | $300.00K 10-Q · filed 2018-11-07 | $1.50M derived: sum of 2 quarters · filed 2018-11-07 | ||
| 2018-06-30 | $1.20M 10-Q · filed 2018-08-08 | |||
| 2017-12-30 | $1.75M 10-K · filed 2020-02-11 | |||
| 2016-12-31 | $918.00K 10-K · filed 2019-02-13 | |||
| 2015-12-26 | $1.95M 10-K · filed 2018-02-13 | |||
| 2014-12-27 | $308.00K 10-K · filed 2017-02-14 | -$308.00K 10-K · filed 2015-02-17 | ||
| 2014-03-29 | $24.00K 10-Q · filed 2014-04-30 | |||
| 2013-12-28 | $15.25M 10-K · filed 2016-02-12 | |||
| 2012-12-29 | $3.06M 10-K · filed 2015-02-17 | |||
| 2011-12-31 | $6.93M 10-K · filed 2014-02-25 | |||
| 2010-12-25 | $0.00 10-K · filed 2013-02-27 | |||
| 2009-12-26 | $10.11M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |